
Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (3): 250-255.doi: 10.11958/20231036
• Cell and Molecular Biology • Previous Articles Next Articles
XIANG Jinjie(
), LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao△(
)
Received:2023-07-12
Revised:2023-09-02
Published:2024-03-15
Online:2024-03-13
Contact:
△E-mail: XIANG Jinjie, LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao. Molecular mechanisms of Ca2+-induced pyroptosis and adhesion changes of HK-2 cells in the formation of calcium-containing kidney stones[J]. Tianjin Medical Journal, 2024, 52(3): 250-255.
CLC Number:
| 基因名称 | 引物序列(5'→3') | 产物大小/bp |
|---|---|---|
| NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
| 下游:TCTGATTAGTGCTGAGTA | ||
| Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
| GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
| IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
| IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
| OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
| CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
| MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
| GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
Tab.1 The sequences of primers for qRT-PCR
| 基因名称 | 引物序列(5'→3') | 产物大小/bp |
|---|---|---|
| NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
| 下游:TCTGATTAGTGCTGAGTA | ||
| Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
| GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
| IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
| IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
| OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
| CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
| MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
| GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
| 组别 | 存活率 | 凋亡率 |
|---|---|---|
| 对照组 | 100.00±2.03 | 2.15±0.83 |
| 0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
| 0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
| 1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
| 2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
| 4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
| 8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
| F | 820.800** | 19.970* |
Tab.2 Comparison of cell survival rate and apoptosis rate between seven groups
| 组别 | 存活率 | 凋亡率 |
|---|---|---|
| 对照组 | 100.00±2.03 | 2.15±0.83 |
| 0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
| 0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
| 1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
| 2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
| 4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
| 8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
| F | 820.800** | 19.970* |
| 组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
| 1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
| 2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
| F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** | |
Tab.3 Comparison of mRNA expression levels between three groups
| 组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
| 1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
| 2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
| F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** | |
| 组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
|---|---|---|---|---|---|
| 对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
| 1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
| 2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
| F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
Tab.4 Comparison of protein expression levels between three groups
| 组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
|---|---|---|---|---|---|
| 对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
| 1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
| 2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
| F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
| 组别 | IL-1β | IL-18 | MCP-1 |
|---|---|---|---|
| 对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
| 1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
| 2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
| F | 231.700** | 224.800** | 102.500** |
Tab.5 Comparison of IL-1β, IL-18 and MCP-1 contents in the supernatant of cell culture between three groups
| 组别 | IL-1β | IL-18 | MCP-1 |
|---|---|---|---|
| 对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
| 1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
| 2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
| F | 231.700** | 224.800** | 102.500** |
| [1] | FRANK D, VINCE J E. Pyroptosis versus necroptosis: similarities,differences,and crosstalk[J]. Cell Death Differ, 2019, 26(1):99-114. doi:10.1038/s41418-018-0212-6. |
| [2] | JACKSON D N, THEISS A L. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer[J]. Gut Microbes, 2020, 11(3):285-304. doi:10.1080/19490976.2019.1592421. |
| [3] | HUTTON H L, OOI J D, HOLDSWORTH S R, et al. The NLRP3 inflammasome in kidney disease and autoimmunity[J]. Nephrology (Carlton), 2016, 21(9):736-744. doi:10.1111/nep.12785. |
| [4] | LI X, ZENG L, CAO C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy[J]. Exp Cell Res, 2017, 350(2):327-335. doi:10.1016/j.yexcr.2016.12.006. |
| [5] | XU G, YUE F, HUANG H, et al. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis[J]. Aging(Albany NY), 2016, 8(5):977-985. doi:10.18632/aging.100957. |
| [6] | HOU J, ZHAO R, XIA W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis[J]. Nat Cell Biol, 2020, 22(10):1264-1275. doi:10.1038/s41556-020-0575-z. |
| [7] | THONGPRAYOON C, KRAMBECK A E, RULE A D. Determining the true burden of kidney stone disease[J]. Nat Rev Nephrol, 2020, 16(12):736-746. doi:10.1038/s41581-020-0320-7. |
| [8] | THONGBOONKERD V. Proteomics of crystal-cell interactions:a model for kidney stone research[J]. Cells, 2019, 8(9):1076. doi:10.3390/cells8091076. |
| [9] | COE F L, WORCESTER E M, EVAN A P. Idiopathic hypercalciuria and formation of calcium renal stones[J]. Nat Rev Nephrol, 2016, 12(9):519-533. doi:10.1038/nrneph.2016.101. |
| [10] | DAUDON M, HENNEQUIN C, BOUJELBEN G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers[J]. Kidney Int, 2005, 67(5):1934-1943. doi:10.1111/j.1523-1755.2005.00292.x. |
| [11] | ANDERS H J, SUAREZ-ALVAREZ B, GRIGORESCU M, et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury[J]. Kidney Int, 2018, 93(3):656-669. doi:10.1016/j.kint.2017.09.022. |
| [12] | KHAN S R, CANALES B K, DOMINGUEZ-GUTIERREZ P R. Randall's plaque and calcium oxalate stone formation:role for immunity and inflammation[J]. Nat Rev Nephrol, 2021, 17(6):417-433. doi:10.1038/s41581-020-00392-1. |
| [13] | RIZVI S H M, PARVEEN A, AHMAD I, et al. Aluminum activates PERK-EIF2α signaling and inflammatory proteins in human neuroblastoma SH-SY5Y cells[J]. Biol Trace Elem Res, 2016, 172(1):108-119. doi:10.1007/s12011-015-0553-7. |
| [14] | KHASKHALI M H, BYER K J, KHAN S R. The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury[J]. Urol Res, 2009, 37(1):1-6. doi:10.1007/s00240-008-0160-6. |
| [15] | JOSHI S, WANG W, PECK A B, et al. Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys[J]. J Urol, 2015, 193(5):1684-1691. doi:10.1016/j.juro.2014.11.093. |
| [16] | LIN Q, LI S, JIANG N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biol, 2019, 26:101254. doi:10.1016/j.redox.2019.101254. |
| [17] | LIU Q, LIU Y, GUAN X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals[J]. Kidney Blood Press Res, 2019, 44(4):777-791. doi:10.1159/000501558. |
| [18] | QI S, WANG Q, XIE B, et al. P38 MAPK signaling pathway mediates COM crystal-induced crystal adhesion change in rat renal tubular epithelial cells[J]. Urolithiasis, 2020, 48(1):9-18. doi:10.1007/s00240-019-01143-z. |
| [19] | KHAN S R. Reactive oxygen species,inflammation and calcium oxalate nephrolithiasis[J]. Transl Androl Urol, 2014, 3(3):256-276. doi:10.3978/j.issn.2223-4683.2014.06.04. |
| [20] | QIN B, WANG Q, LU Y, et al. Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by inhibiting NADPH oxidase and oxidative stress[J]. Oxid Med Cell Longev, 2018, 2018:1271864. doi:10.1155/2018/1271864. |
| [21] | ASSELMAN M, VERHULST A, DE BROE M E, et al. Calcium oxalate crystal adherence to hyaluronan-,osteopontin-,and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys[J]. J Am Soc Nephrol, 2003, 14(12):3155-3166. doi:10.1097/01.asn.0000099380.18995.f7. |
| [22] | WANG Z, LI M X, XU C Z, et al. Comprehensive study of altered proteomic landscape in proximal renal tubular epithelial cells in response to calcium oxalate monohydrate crystals[J]. BMC Urol, 2020, 20(1):136. doi:10.1186/s12894-020-00709-z. |
| [1] | FU Nannan, LIU Tao, LI Juan, ZHAO Yu. Regulative effect of tripterine on oxidative stress and senescence in hepatocellular carcinoma cells [J]. Tianjin Medical Journal, 2026, 54(7): 681-686. |
| [2] | QI Lin, AN Meiting, FANG Bolong. Predictive value of serum ceruloplasmin and kidney injury molecule-1 for the occurrence of end-stage renal disease [J]. Tianjin Medical Journal, 2026, 54(7): 716-721. |
| [3] | CUI Zhigang, YING Ce, ZHANG Cen, LI Dihua, ZHUO Yuzhen, YANG Lei. The protective effect of exosomes derived from bolbostemma paniculatum on sepsis-induced acute lung injury [J]. Tianjin Medical Journal, 2026, 54(6): 591-597. |
| [4] | PANG Jing, JIAO Yan, ZHU Haili, GAO Fang, LI Junjie, LI Xuefeng. Prediction value of APD combined with RCT grading for fetal renal pelvis dilatation and neonatal renal function [J]. Tianjin Medical Journal, 2026, 54(5): 489-493. |
| [5] | ZHAO Zhengwei, XU Wenyan, GUO Xiaomin, WANG Min, LI Jianli, LI Zhihai, SHEN Dongqiong, TU Yungui. Predictive value of serum LRG1 and suPAR levels in sepsis patients with concurrent acute kidney injury [J]. Tianjin Medical Journal, 2026, 54(4): 374-378. |
| [6] | ZHOU Yuke, SUN Wei, GAO Qing, HE Jun. The effect of sevoflurane on neuronal inflammation in rats with spinal cord injury by regulating the ROS/TXNIP/NLRP3 pathway [J]. Tianjin Medical Journal, 2025, 53(9): 910-915. |
| [7] | MA Liang, HU Liying, SHI Yu, ZHAO Yongan, SUN Yasi, SUN Guangdong. Analysis of macular retinal thickness characteristics in diabetic kidney disease patients with different blood pressure levels [J]. Tianjin Medical Journal, 2025, 53(9): 923-926. |
| [8] | LIU Haiwei, YANG Jie, WANG Li, MENG Shibo, TANG Xusong, LIU Chengren, WANG Yongwang. Luteolin inhibits glioblastoma by regulating ROS levels via the NFE2L2/x-CT/GPX4 signalling axis [J]. Tianjin Medical Journal, 2025, 53(7): 673-678. |
| [9] | NI Man, GE Jun, KONG Ziang. Correlation analysis of HMGB1 and MCP-1 levels and prognosis of patients with sepsis combined with AKI [J]. Tianjin Medical Journal, 2025, 53(3): 297-301. |
| [10] | HUANG Yeni, DONG Yangzhou, HU Miaoqing, LI Wei, LIU Yang. Effects of Shen 'an decoction on immunity, renal function and lipid metabolism in patients with chronic renal insufficiency [J]. Tianjin Medical Journal, 2025, 53(12): 1309-1314. |
| [11] | ZHENG Xuzhou, LIU Yan, GAO Yufeng, CHEN Rui, ZHANG Xuan. A case of pediatric kidney abscess caused by Bacteroides fragilis [J]. Tianjin Medical Journal, 2025, 53(12): 1330-1333. |
| [12] | GAO Chen, QIAO Yunyang, JI Jialing, WANG E, HUO Ying, ZHANG Aiqing. The effect of bufalin on extracellular matrix synthesis in renal tubular epithelial cells induced by high glucose [J]. Tianjin Medical Journal, 2025, 53(10): 1009-1015. |
| [13] | WU Yameng, LI Liangliang, WANG Yangang, XING Defu. Predictive value of serum APOC1 and Klotho expression for prognosis in patients undergoing laparoscopic partial nephrectomy for renal cancer [J]. Tianjin Medical Journal, 2025, 53(1): 61-64. |
| [14] | SONG Hu, ZHU Jian, FU Yongmei, ZHANG Yongbiao, ZHENG Changlong. The value of combined detection of PCT, IL-6 and CysC for the diagnosis and prognosis assessment of septic acute kidney injury [J]. Tianjin Medical Journal, 2025, 53(1): 65-70. |
| [15] | GAO Pan, XIE Bingxin, ZHOU Zandong, LIU Tong. Promoting effect of circulating FGF23 on atrial fibrosis in chronic kidney disease [J]. Tianjin Medical Journal, 2024, 52(9): 917-923. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||